Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery. (2015)

First Author: Powell G
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.12715

PubMed Identifier: 26138622

Publication URI: http://europepmc.org/abstract/MED/26138622

Type: Journal Article/Review

Volume: 80

Parent Publication: British journal of clinical pharmacology

Issue: 5

ISSN: 0306-5251